跳至主要内容
临床试验/CTRI/2026/04/107405
CTRI/2026/04/107405尚未招募2 期

Single Centric Phase II Open clinical trial in Maga Vatham(Irritable bowel syndrome) with siddha medicine Sundai Vatral Chooranam.

Dr K Jamuna1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2026年5月4日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
44
试验地点
1

研究概览

简要总结

This is Single Centric Phase II Open clinical trial in Maga Vatham (Irritable bowel syndrome) with siddha medicine Sundai Vatral Chooranam.

The Dosage of Sundai Vatral Chooranam 750 mg ( twice a day )  with erumai thayir for 48 days .

The Sample Size  for the study is 44.

Outcome is assessed by IBS-Symptom Severity Scale(IBS-SSS)

Severe to Moderate,

Moderate to mild.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Based upon the Rome IV criteria Recurrent abdominal pain or discomfort at least 1 day per week on average in the last 3 months (onset at least 6 months before diagnosis),associated with two or more of the followings Related to defecation, Onset associated with a change in frequency of stool, Onset associated with a change in form (appearance) of stool.

排除标准

  • Postinfectious IBS (Campylobacter,Salmonella,and Shigella) Known Complaints of Inflammatory Bowel Disease(IBD) , Ulcerative colitis, Crohn’s disease, Autoimmune inflammatory disease Amoebic dysentery.

研究者

发起方
Dr K Jamuna
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr K Jamuna

GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI

研究点 (1)

Loading locations...

相似试验